Search results for: 'parc pois analysis for laboratory develop'

30 Mar 2023  |  North America  |  Customer Research

Global Laboratory Product Purchasing Trends, 2022–2023

End–user Perspectives on Laboratory Spending Reveals Modest 2023 Budget Increases Following robust 2022 Spending

Infographics

×

Readers of one of Frost & Sullivan’s media partners were invited to participate in an online survey from October to November 2022 examining their laboratories’ product purchasing process in 2022 and expectations for 2023. Frost & Sullivan has conducted similar studies among the same targeted respondents since 2012. The study presents year-over-...

Clinical diagnostics, life science research, genomics and proteomics, and drug discovery labs are adopting lab automation solutions to overcome tremendous operational pressure because of the demand for high throughput and shortage of technicians. Solutions that automate pre-analytical, analytical, and post-analytical processes are available. The re...

Single-cell analysis can diagnose a condition in heterogenous cell population samples by studying genomics, transcriptomics, proteomics, metabolomics, and other cellular interactions in cells. It helps to understand a tumor microenvironment better and develop drugs based on newly uncovered knowledge of various types of tumors. The rich data provide...

With increased interest in precision medicine and demand for telemedicine and digital solutions in hospitals and laboratories, digital pathology has the opportunity to grow in its clinical, pharma, and research applications. Advances in AI-based algorithms and data management and analysis software offer immense potential in improving workflow, aut...

The laboratory information management systems (LIMS) industry in the United States and Europe is forecast to grow from 2023 to 2027 at a CAGR of 8.8% and 6.3%, respectively, driven by the increasing need for laboratory automation, regulatory compliance, and cloud-based solutions. Prominent players in the US and EU LIMS industries, such as ThermoFis...

Sequencing technologies have evolved over the years to harness the value of the human genome and dive deep into DNA and RNA sequences which offer immense knowledge of human biology. From Sanger sequencing to next-generation sequencing, technologies and chemistries have improved/advanced to reduce costs and ensure faster timelines. NGS has integrate...

The healthcare industry is undergoing a massive transformation, with a high focus on personalization and patient-centric care. It is embracing digital transformation and becoming more consumer-/patient friendly. The changing socioeconomic landscape, the high prevalence of chronic diseases, the massive COVID-19 pandemic, and the challenge of resourc...

The SynBio field has evolved well over the past two decades, with significant technology disruptions leading to new opportunities and remarkable growth potential. Advances in SynBio technologies have transformed drug discovery and therapeutics development, accelerating the identification of novel drug targets and high-throughput compound screening ...

02 May 2023  |  Global  |  Technology Research

Technology Advances in Senolytics

Innovative Drug Development Culture Working to Prolong Health Spans and Eliminate Aging Cells

Infographics

×

Senolytics is a relatively new field of development that falls under the broad category of senotherapeutics, along with senomorphics and senostatics. Although nascent, the field could address the root causes of most chronic conditions brought on by aging as it clears senescent cells that have ceased to multiply (and ideally are eliminated from the ...